Merck Animal Health Introduces Next Generation of Circovirus Protection

Merck Animal Health has introduced the first porcine circovirus Type 2 (PCV2) vaccine, Circumvent PCV G2, for use in pigs as early as 3 days of age in a one- or two-dose formulation. The vaccine offers five-month duration of immunity (DOI), at least 25% longer than any other PCV2 vaccine on the market, the company claims.

Merck Animal Health has introduced the first porcine circovirus Type 2 (PCV2) vaccine, Circumvent PCV G2, for use in pigs as early as 3 days of age in a one- or two-dose formulation. The vaccine offers five-month duration of immunity (DOI), which the company claims is at least 25% longer than any other PCV2 vaccine on the market. "Vaccines with longer DOI can provide better protection and potentially reduce mortality just prior to marketing, where the loss of a pig approaches market value," says Derald Holtkamp, DVM, Iowa State University. "In a barn of 1,000 pigs, if just one, 270-lb. pig is saved, and carcass prices are at $1 per pound, the benefit is more than $200 or $.20 per pig." To learn more visit www.Circumvent-G2.com or contact a Merck representative at (800) 211-3573. 

You can still get free marketing insights!

Missed our USDA Report marketing seminar? View it on demand and benefit from the insights and analysis that will help your bottom line.

How USDA Report Will Impact Crop Prices
And Your Bottom Line

Check it out now

NEW! Get the Blueprint app now!

The new Blueprint app is the pork industry's most in-depth view of management practices, production stages and pork industry challenges — now at your fingertips.

Download your Blueprint app today!

Newsletter Signup

Search 3.8+ million listings

Sponsored Introduction Continue on to (or wait seconds) ×